Killer Boob
Wednesday, December 5, 2012
PD-991 with Femara
CDK inhibitor along with femara giving 26months PFS instead of <10 months PFS with femara alone. Phase II trial only. But still impressive.
http://www.fool.com/investing/businesswire/2012/12/05/pfizer-presents-phase-2-data-showing-investigation.aspx
http://erc.endocrinology-journals.org/content/18/4/C19.long
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment